Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PER Pulse™ Recaps
for the Renal Cell Carcinoma: Recent Advances and New Questions symposium focus on current treatment algorithms, new agents, and management of adverse events in patients with renal cell carcinoma that were discussed by the expert faculty at this program.
This activity is supported by an educational grant from Exelixis.
Release Date: March 31, 2016
Expiration Date: March 31, 2017
Media: Internet - based
This activity focuses on the field of renal cell carcinoma (RCC) management, and features a series of short video interviews with leading experts in the treatment of renal cell carcinoma. The content and interviews are based on presentations given at Renal Cell Carcinoma: Recent Advances and New Questions, a CME-certified, ancillary satellite symposium held in San Francisco, California.
Instructions For This Activity & Receiving Credit
This educational activity is intended for medical oncologists, surgical oncologists, radiation oncologists, urologists, and other healthcare professionals interested in the treatment of renal cell carcinoma.
Toni Choueiri, MD
Clinical Director, Lank Center for Genitourinary Oncology
Director, Kidney Cancer Center
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Robert Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology-Oncology
Professor of Biomedical Sciences
Professor of Medicine
Director, Division of Hematology/Oncology
Cedars-Sinai Medical Center
Associate Director, Academic Program Development in the Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
Hans Joerg Hammers, MD, PhD
Assistant Professor of Oncology, Johns Hopkins School of Medicine
Medical Oncologist, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Brian Rini, MD, FACP
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Department of Solid Tumor Oncology, Cleveland Clinic
The staff of Physicians' Education Resource®, LLC
It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY